antihistamine: be contraindicated in bph

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents medicine
Weight: 0.69
, medication
Weight: 0.67
, cold medicine
Weight: 0.61
, drug
Weight: 0.60
, prescription
Weight: 0.58
Siblings ranitidine
Weight: 0.42
, acetaminophen
Weight: 0.37
, ibuprofen
Weight: 0.37
, phenobarbital
Weight: 0.37
, sedative
Weight: 0.36

Related properties

Property Similarity
be contraindicated in bph 1.00
be contraindicated in hypertension 0.90
be contraindicated in asthma 0.89
be contraindicated in glaucoma 0.88
is anticholinergic 0.75

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.07
Rule weight: 0.13
Evidence weight: 0.62
Similarity weight: 0.89
Evidence: 0.63
¬ Remarkable(antihistamine, be contraindicated in bph) ⋁
Evidence: 0.59
¬ Remarkable(ibuprofen, be contraindicated in asthma)

Remarkability from sibling implausibility

0.50
Rule weight: 0.60
Evidence weight: 0.93
Similarity weight: 0.89
Evidence: 0.79
Plausible(antihistamine, be contraindicated in bph) ⋁
Evidence: 0.59
Remarkable(ibuprofen, be contraindicated in asthma) ⋁
Evidence: 0.79
¬ Plausible(ibuprofen, be contraindicated in asthma)

Salient implies Plausible

0.23
Rule weight: 0.28
Evidence weight: 0.82
Similarity weight: 1.00
Evidence: 0.79
Plausible(antihistamine, be contraindicated in bph) ⋁
Evidence: 0.86
¬ Salient(antihistamine, be contraindicated in bph)

Similarity expansion

0.67
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.90
Evidence: 0.86
Salient(antihistamine, be contraindicated in bph) ⋁
Evidence: 0.95
¬ Salient(antihistamine, be contraindicated in hypertension)
0.66
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.88
Evidence: 0.86
Salient(antihistamine, be contraindicated in bph) ⋁
Evidence: 0.90
¬ Salient(antihistamine, be contraindicated in glaucoma)
0.66
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.89
Evidence: 0.86
Salient(antihistamine, be contraindicated in bph) ⋁
Evidence: 0.96
¬ Salient(antihistamine, be contraindicated in asthma)
0.66
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.90
Evidence: 0.83
Typical(antihistamine, be contraindicated in bph) ⋁
Evidence: 0.85
¬ Typical(antihistamine, be contraindicated in hypertension)
0.65
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.88
Evidence: 0.83
Typical(antihistamine, be contraindicated in bph) ⋁
Evidence: 0.78
¬ Typical(antihistamine, be contraindicated in glaucoma)
0.65
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.89
Evidence: 0.83
Typical(antihistamine, be contraindicated in bph) ⋁
Evidence: 0.88
¬ Typical(antihistamine, be contraindicated in asthma)
0.63
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.90
Evidence: 0.79
Plausible(antihistamine, be contraindicated in bph) ⋁
Evidence: 0.84
¬ Plausible(antihistamine, be contraindicated in hypertension)
0.63
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.88
Evidence: 0.79
Plausible(antihistamine, be contraindicated in bph) ⋁
Evidence: 0.78
¬ Plausible(antihistamine, be contraindicated in glaucoma)
0.63
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.75
Evidence: 0.83
Typical(antihistamine, be contraindicated in bph) ⋁
Evidence: 0.15
¬ Typical(antihistamine, is anticholinergic)
0.62
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.89
Evidence: 0.79
Plausible(antihistamine, be contraindicated in bph) ⋁
Evidence: 0.86
¬ Plausible(antihistamine, be contraindicated in asthma)
0.59
Rule weight: 0.85
Evidence weight: 0.92
Similarity weight: 0.75
Evidence: 0.79
Plausible(antihistamine, be contraindicated in bph) ⋁
Evidence: 0.37
¬ Plausible(antihistamine, is anticholinergic)
0.59
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.75
Evidence: 0.86
Salient(antihistamine, be contraindicated in bph) ⋁
Evidence: 0.65
¬ Salient(antihistamine, is anticholinergic)
0.56
Rule weight: 0.85
Evidence weight: 0.72
Similarity weight: 0.90
Evidence: 0.63
Remarkable(antihistamine, be contraindicated in bph) ⋁
Evidence: 0.75
¬ Remarkable(antihistamine, be contraindicated in hypertension)
0.55
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.89
Evidence: 0.63
Remarkable(antihistamine, be contraindicated in bph) ⋁
Evidence: 0.74
¬ Remarkable(antihistamine, be contraindicated in asthma)
0.55
Rule weight: 0.85
Evidence weight: 0.72
Similarity weight: 0.88
Evidence: 0.63
Remarkable(antihistamine, be contraindicated in bph) ⋁
Evidence: 0.75
¬ Remarkable(antihistamine, be contraindicated in glaucoma)
0.42
Rule weight: 0.85
Evidence weight: 0.65
Similarity weight: 0.75
Evidence: 0.63
Remarkable(antihistamine, be contraindicated in bph) ⋁
Evidence: 0.95
¬ Remarkable(antihistamine, is anticholinergic)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.93
Similarity weight: 1.00
Evidence: 0.86
Salient(antihistamine, be contraindicated in bph) ⋁
Evidence: 0.83
¬ Typical(antihistamine, be contraindicated in bph) ⋁
Evidence: 0.63
¬ Remarkable(antihistamine, be contraindicated in bph)

Typical implies Plausible

0.39
Rule weight: 0.48
Evidence weight: 0.82
Similarity weight: 1.00
Evidence: 0.79
Plausible(antihistamine, be contraindicated in bph) ⋁
Evidence: 0.83
¬ Typical(antihistamine, be contraindicated in bph)

Typicality and Rermarkability incompatibility between siblings

0.06
Rule weight: 0.14
Evidence weight: 0.46
Similarity weight: 0.89
Evidence: 0.63
¬ Remarkable(antihistamine, be contraindicated in bph) ⋁
Evidence: 0.85
¬ Typical(ibuprofen, be contraindicated in asthma)